Xero

Xero Add to your watchlist.

1H26: Overall, a weaker result vs market expectations despite EBITDA a slight beat. EBITDA-capex cash flow came in -6% below consensus. Whilst operating costs have seen good control, capex spend is trending up due to investments in new AI capabilities.

You’re not a member!  Trial today

Look for buying interest to rebuild, and we’ll revisit the entry point once the price action is above the 10-day average.

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.